key: cord-0903028-7ij09wg6
authors: McAlister, Finlay A.; Whitten, Tara A.; King, James A.; Bakal, Jeffrey A.
title: Which adults presenting for SARS-CoV-2 testing are most likely to have a positive swab? A population-based cohort of 15,132 adults from Alberta, Canada
date: 2020-12-04
journal: Chest
DOI: 10.1016/j.chest.2020.11.043
sha: 431f956df82b6cb07760907820f6eff4ae48441d
doc_id: 903028
cord_uid: 7ij09wg6

nan

Few studies have examined the frequency and importance of symptoms in patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.

Those that have been done were mostly small, often did not include individuals without SARS-CoV-2 infection, were retrospective (with attendant high risk of recall bias), and/or have focused only on hospitalized or emergency department patients. 1 We describe symptoms in adult outpatients being tested for SARS-CoV-2 infection, and examine which are associated with having a positive reverse transcription polymerase chain reaction (RT-PCR) swab for SARS-CoV-2.

We conducted a prospective cohort study using data collected from every Albertan 18 years or older (including self-identified healthcare workers) who had a positive test for SARS-CoV-2 or underwent swabbing for contact tracing due to a high risk exposure (most commonly household contacts of a COVID-19 patient) between March 1 and September 30, 2020. All data was collected using standardized questionnaires and entered into the Communicable Disease Outbreak Management (CDOM) database. As only patients with COVID-19 and high-risk contacts are eligible for CDOM, individuals who presented to a testing site with symptoms but were swab negative were not included. There was no missing data since we analyzed mandatory required fields in the reporting form. For patients who were tested multiple times, we only examined the data related to their first swab. Alberta has a publicly funded, universal access health care system with integration of data from all hospitals and public health testing facilities in the province. The University of Alberta Health Research J o u r n a l P r e -p r o o f Ethics Board (Pro00101096) approved this project with a waiver of informed consent as all analyses were conducted using de-identified data.

We explored the associations between symptoms and SARS-CoV-2 swab positivity using positive likelihood ratios (PLR) since they are less influenced by underlying prevalence of the disease than odds ratios or positive predictive values. 2 As the CDOM eligibility criteria could distort the underlying population distribution, we also performed a sensitivity analysis in only those adults being swabbed by Alberta Public Health as they were high-risk contacts.

Between March 1 and September 30, 12377 adult Albertans had at least one positive RT-PCR swab for SARS-CoV-2 and 11702 (95%) completed the CDOM questionnaire (mean age 42.6, SD 16.6 years). Another 3430 adult Albertans (mean age 42.6, SD 15.8 years) who were contact traced and completed the symptom questionnaire but subsequently had a negative RT-PCR swab for SARS-CoV-2 were included.

The most commonly reported symptoms in the 11702 adults with positive tests (only 5% of whom were hospitalized) were cough (49%), fever (41%), headache (34%), and sore throat (28%), but these were also common symptoms in the 3430 high-risk contacts who were swab negative ( Table 1 ). The symptoms most strongly associated with a positive SARS-CoV-2 swab were anosmia/ageusia, decreased appetite, diarrhea, nausea/vomiting, malaise, muscle/joint pain, sneezing, fever/chills, and headache (Table 1) . Cough, sore throat, and dyspnea were not associated with positive swab results in the general population. Amongst healthcare workers, anosmia/ageusia, J o u r n a l P r e -p r o o f decreased appetite, fever/chills, muscle/joint pain, malaise, nasal congestion, cough, dyspnea, and headache were predictive of swab positivity (Table 1) .

PLR were similar in men and women (Figure 1 ), in the sensitivity analysis restricted to the 9153 individuals who were swabbed for high-risk contact tracing (5723 of whom were positive for SARS-CoV-2), and in healthcare workers - Table 1 . We also found that individuals with swab tests positive for SARS-CoV-2 were more likely to be men, older, current smokers of cigarettes or cannabis, or users of vaping products (Table 1) .

In adult outpatients, we found that upper respiratory tract symptoms were less predictive of SARS-CoV-2 infection than anosmia/ageusia or decreased appetite (which were the only symptoms which appreciably altered the likelihood of a patient having a positive swab). Symptom patterns and PLR were similar in healthcare workers.

Although the frequency of some symptoms in our cohort were lower than reported in prior studies, 1,3-8 that is not surprising since most of those studies included only hospitalized patients and were retrospective. While many prior studies did not systematically collect data on anosmia/ageusia, our results confirm reports which examined free text of smartphone app entries or telehealth visit interactions and found that the words "taste", "sense" and "lost" were used with much higher frequency by patients with SARS-CoV-2 than those who tested negative, with an OR of 6.7 for test positivity. 3, 8 Despite our large sample size and symptom information from adults who tested positive or negative for SARS-CoV-2, our study does have some limitations. For one, J o u r n a l P r e -p r o o f the standardized questionnaire did not include anosmia/ageusia until August 15before then, we had to extract that symptom from the free text area of the questionnaire where patients could report any other symptoms without prompting. The fact that anosmia/ageusia had the largest PLR of all symptoms both pre-and post-August 15 is reassuring, but the frequency would undoubtedly have been higher if anosmia/ageusia were included in the standard questionnaire from the start or if odorant exposure tests were used (a European study 4 reported loss of smell in 87% of COVID-19 patients and loss of taste in 56%). Second, there is some potential for misclassification of SARS-CoV-2 status given the less than 100% sensitivity and specificity of RT-PCR testing for SARS-CoV-2 9 ; however, any misclassification is likely to have biased towards the null and reduced the strength of our reported associations between symptoms and swab positivity. Third, we do not have symptom data from all patients who had a negative RT-PCR swab in Alberta as the CDOM database only included negative patients who were being contact traced. While this could potentially distort underlying population frequencies and findings, the fact that the PLRs for the sensitivity analysis restricted to high-risk contacts were similar to those from the main analysis provides reassurance that the associations we found between symptoms and SARS-CoV-2 positivity were not unduly influenced by CDOM eligibility criteria. Fourth, it is unknown if the symptoms associated with SARS-CoV-2 infection will change with seasonality.

Nevertheless, we were able to define those symptoms which were most strongly associated with SARS-CoV-2 infection in adult outpatients and in healthcare workers in an entire Canadian province. Employers or educational institutions using Fitness to

Work symptom questionnaires to screen adults should consider revising their standardized questions accordingly.

We thank Tanya Masson-McCrory, Clinical Educator for the Alberta Health Services Communicable Disease Outbreak Management (CDOM) program and the medical student volunteers who helped collect symptom data from patients included in the CDOM. Dr. McAlister is funded by an AHS Chair in Cardiovascular Outcomes Research and this project was supported by the Alberta Strategy for Patient Oriented Research Support Unit. This study is based in part on data provided by Alberta Health and Alberta Health Services. The interpretation and conclusions contained herein are those of the researchers and do not represent the views of the Government of Alberta or Alberta Health Services. Neither the Government of Alberta nor Alberta Health Services express any opinion in relation to this study.

Author Contributions: FAM conceived and designed the study and wrote the manuscript, he is the guarantor for the work; TAW and JAK collected and analyzed the data under the supervision of JAB; all authors revised the manuscript. 

Prediction models for diagnosis and prognosis of Covid-19 infection: systematic review and critical appraisal

Simplifying likelihood ratios

Real-time tracking of self-reported symptoms to predict potential COVID-19

Loss of smell and taste in 2013 European patients with mild to moderate Covid

Olfactory Dysfunction: A Highly Prevalent Symptom of COVID-19 With Public Health Significance

The role of self-reported olfactory and gustatory dysfunction as a screening criterion for suspected COVID-19

Acute-onset smell and taste disorders in the context of COVID-19: a pilot multicentre polymerase chain reaction based case-control study

An AI approach to COVID-19 infection risk assessment in virtual visits: a case report

7%) N/A Cannabis smoker 291 (2.5%) 22 (0.6%) 3.88 (2.52, 5.97) 3.84 (2.46, 6.01) 20 (1.6%) N/A Symptoms: Anosmia/ageusia 2300

81) Chest pain 589 (5.0%) 99 (2.9%) 1.74 (1.41, 2.15) 1.07 (0.84, 1.37) 54 (4.3%) 3.73 (0.92, 15.16) Conjunctivitis 91 (0.8%) 19 (0.6%) 1.40 (0.86, 2.30) 1.10 (0.63, 1.93) 12 (1.0%) N/A Nasal congestion 2456

Footnote: malaise = general feeling of discomfort or not feeling well; fatigue = tiredness; asymptomatic = answered no to all questions on the standardized symptom questionnaire and did not report any other symptoms in the free-text field